Mitigating Risk in Manufacturing with Rapid Microbial Monitoring in Pharmaceutical Water

Prevoiusly Aired on May 11th, 2022

Sign Up:

(*) denotes required form field(s)

Our registration process uses cookies, by submitting this registration form you agree to our cookie policy.

  Register

Overview

Today online detection methods for monitoring the microbial health of water systems are available. Pharmaceutical companies and their contract manufacturers are increasingly considering the value of online microbial testing.

In this webinar we discuss examples of real-world conversations as pharmaceutical customers grapple with true microbial contaminations within their water systems. As they dig into the root causes of these events, investigators are realizing the value of automating quality.

The assurance of transparency that real time monitoring provides allows them to see that their water system is under control and not a contamination source.

In this webinar you’ll learn:

  • Costs of risk and their impact on quality
  • How to mitigate the risks of future microbial events
  • The benefits of combining on line detection of TOC and bioburden with conventional microbial detection methods
Who should attend:
  • Microbiologists
  • Process Engineers
  • CEO/CFO
  • Pharmaceutical Water owners
  • Quality Control Water process engineers
  • QA, QC
  • Metrologists and persons responsible for system operation and analytical instrument selection, operation/maintenance
  • Microbiologists
  • Process Engineers
  • R&D scientists
  • Process Development
  • Bioprocessing engineers at pilot and manufacturing scale
  • Contract development manufacturing


Presenters

Presenter
Peggy Banarhall
(Presenter)
Head of Product Marketing, Process Analytics
Mettler Toledo
View Biography
Presenter
Tracy Radcliffe
(Presenter)
Microbial Specialist
Mettler Toledo
View Biography
Presenter
Areen Kalantari
(Presenter)
Global Segment Specialist –Biopharm / Pharmaceuticals
Mettler Toledo
View Biography
Presenter
Mike Auerbach
(Moderator)
Editor-in-Chief,
American Pharmaceutical Review